4.7 Article

Altered Concentrations of Amyloid Precursor Protein Metabolites in the Cerebrospinal Fluid of Patients with Bipolar Disorder

期刊

NEUROPSYCHOPHARMACOLOGY
卷 38, 期 4, 页码 664-672

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2012.231

关键词

amyloid precursor protein; Tau protein; biomarkers; bipolar disorder; cerebrospinal fluid

资金

  1. Stockholm County Council [ALF 20100305]
  2. Karolinska Institutet [ALF 20100305]
  3. Swedish Medical Research Council [K2008-62x-14647-06-3, K2010-61X-21569-01-1, K2010-61P-21568-01-4]
  4. Brain foundation
  5. Soderberg Foundation
  6. Alzheimer's Association
  7. Swedish foundation for Strategic research
  8. AstraZeneca
  9. Lundbeck pharmaceuticals
  10. Eli Lilly Sweden
  11. Wyeth
  12. Servier Sweden

向作者/读者索取更多资源

Bipolar disorder is a psychiatric disorder characterized by recurrent episodes of mania/hypomania and depression. Progressive cognitive dysfunction such as impairments in executive function and verbal memory is common in euthymic bipolar patients. The cerebrospinal fluid has previously been used to study neurodegenerative processes in Alzheimer's disease, from which changes in three core biomarkers have emerged as indicative of degeneration: amyloid beta, total tau, and hyperphosphorylated tau. Here, neurodegeneration in bipolar disorder was investigated by assessing the association between bipolar disorder and cerebrospinal fluid biomarkers for neurodegenerative processes. Cerebrospinal fluid was obtained from 139 bipolar disorder patients and 71 healthy controls. Concentrations of total and phosphorylated tau, amyloid beta 1-42, amyloid beta 38/beta 40/beta 42, and the soluble forms of amyloid precursor protein were measured in patients vs controls. The concentrations of the soluble forms of amyloid precursor protein were significantly lower in bipolar patients compared with controls. The amyloid beta 42/amyloid beta 38 and the amyloid beta 42/amyloid beta 40 ratios were higher in bipolar patients than controls. There were no discernible differences in the concentrations of total/phosphorylated tau, amyloid beta 1-42, or amyloid beta 38/beta 40/beta 42. The concentrations of the biomarkers within the bipolar patient group were further associated with different ongoing medical treatments and diagnostic subgroups. The findings suggest that the amyloid precursor protein metabolism is altered in bipolar disorder. The results may have implications for the understanding of the pathophysiology of bipolar disorder and for the development of treatment strategies. Importantly, there were no signs of an Alzheimer-like neurodegenerative process among bipolar patients. Neuropsychophormacology (2013) 38, 664-672; doi:10.1038/npp.2012.231; published online 5 December 2012

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment

Anniella Isgren, Joel Jakobsson, Erik Palsson, Carl Johan Ekman, Anette G. M. Johansson, Carl Sellgren, Kaj Blennow, Henrik Zetterberg, Mikael Landen

BRAIN BEHAVIOR AND IMMUNITY (2015)

Article Clinical Neurology

CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment

Sindre Rolstad, Joel Jakobsson, Carl Sellgren, Anniella Isgren, Carl Johan Ekman, Maria Bjerke, Kaj Blennow, Henrik Zetterberg, Erik Palsson, Mikael Landen

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)

Article Psychiatry

CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder

Joel Jakobsson, Erik Palsson, Carl Sellgren, Frida Rydberg, Agneta Ekman, Henrik Zetterberg, Kaj Blennow, Mikael Lander

BRITISH JOURNAL OF PSYCHIATRY (2016)

Article Clinical Neurology

Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders

Viktoria Johansson, Joel Jakobsson, Rebecca G. Fortgang, Henrik Zetterberg, Kaj Blennow, Tyrone D. Cannon, Christina M. Hultman, Lennart Wetterberg, Mikael Landen

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)

Article Biochemistry & Molecular Biology

Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis

N. Yoshimi, T. Futamura, S. E. Bergen, Y. Iwayama, T. Ishima, C. Sellgren, C. J. Ekman, J. Jakobsson, E. Palsson, K. Kakumoto, Y. Ohgi, T. Yoshikawa, M. Landen, K. Hashimoto

MOLECULAR PSYCHIATRY (2016)

Review Clinical Neurology

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Claire Bridel, Wessel N. van Wieringen, Henrik Zetterberg, Betty M. Tijms, Charlotte E. Teunissen, Jose C. Alvarez-Cermeno, Ulf Andreasson, Markus Axelsson, David C. Backstrom, Ales Bartos, Maria Bjerke, Kaj Blennow, Adam Boxer, Lou Brundin, Joachim Burman, Tove Christensen, Lenka Fialova, Lars Forsgren, Jette L. Frederiksen, Magnus Gisslen, Elizabeth Gray, Martin Gunnarsson, Sara Hall, Oskar Hansson, Megan K. Herbert, Joel Jakobsson, Jan Jessen-Krut, Shorena Janelidze, Gudmundur Johannsson, Michael Jonsson, Ludwig Kappos, Mohsen Khademi, Michael Khalil, Jens Kuhle, Mikael Landen, Ville Leinonen, Giancarlo Logroscino, Ching-Hua Lu, Jan Lycke, Nadia K. Magdalinou, Andrea Malaspina, Niklas Mattsson, Lieke H. Meeter, Sanjay R. Mehta, Signe Modvig, Tomas Olsson, Ross W. Paterson, Josue Perez-Santiago, Fredrik Piehl, Yolande A. L. Pijnenburg, Okko T. Pyykko, Oskar Ragnarsson, Julio C. Rojas, Jeppe Romme Christensen, Linda Sandberg, Carole S. Scherling, Jonathan M. Schott, Finn T. Sellebjerg, Isabella L. Simone, Tobias Skillback, Morten Stilund, Peter Sundstrom, Anders Svenningsson, Rosanna Tortelli, Carla Tortorella, Alessandro Trentini, Maria Troiano, Martin R. Turner, John C. van Swieten, Mattias Vagberg, Marcel M. Verbeek, Luisa M. Villar, Pieter Jelle Visser, Anders Wallin, Andreas Weiss, Carsten Wikkelso, Edward J. Wild

JAMA NEUROLOGY (2019)

Article Psychiatry

Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls

Ruyue Zhang, Jie Song, Anniella Isgren, Joel Jakobsson, Kaj Blennow, Carl M. Sellgren, Henrik Zetterberg, Sarah E. Bergen, Mikael Landen

TRANSLATIONAL PSYCHIATRY (2020)

Article Psychiatry

Psychotically driven aggression is associated with greater mentalizing challenges in psychotic spectrum disorders

Anette G. M. Johansson, Malin Kallman, Lennart Hogman, Marianne Kristiansson, Hakan Fischer, Sven Bolte

BMC PSYCHIATRY (2020)

Article Biochemistry & Molecular Biology

Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder

Andreas Goteson, Anniella Isgren, Lina Jonsson, Timea Sparding, Erik Smedler, Aurimantas Pelanis, Henrik Zetterberg, Joel Jakobsson, Erik Palsson, Jessica Holmen-Larsson, Mikael Landen

Summary: The study identified four novel CSF protein associations with bipolar disorder, shedding new light on the central nervous system processes implicated in bipolar disorder.

MOLECULAR PSYCHIATRY (2021)

Article Psychiatry

A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder

Andreas Goteson, Anniella Isgren, Timea Sparding, Jessica Holmen-Larsson, Joel Jakobsson, Erik Palsson, Mikael Landen

Summary: In this study, novel protein associations with bipolar disorder were identified using proximity extension assay in blood serum samples. The researchers found 32 proteins significantly associated with bipolar disorder, with some associations potentially influenced by psychiatric drugs. The study highlighted MMP-7 as a potential biomarker for lithium-induced nephropathy.

TRANSLATIONAL PSYCHIATRY (2022)

Article Biochemistry & Molecular Biology

Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study

Johan Sandberg, Caroline Hansson, Andreas Goteson, Erik Joas, Joel Jakobsson, Erik Palsson, Mikael Landen

Summary: This study aimed to identify novel candidate biomarkers for suicidal behavior. Proteins associated with prospective suicide attempts were identified in patients with bipolar disorder, providing potential targets for suicide prevention.

MOLECULAR PSYCHIATRY (2022)

Article Biochemistry & Molecular Biology

Cerebrospinal fluid proteomic study of two bipolar disorder cohorts

Anniella Isgren, Andreas Goteson, Jessica Holmen-Larsson, Aurimantas Pelanis, Carl Sellgren, Erik Joas, Timea Sparding, Henrik Zetterberg, Erik Smedler, Joel Jakobsson, Mikael Landen

Summary: The pathophysiology of bipolar disorder is not well understood. This explorative study found that cerebrospinal fluid (CSF) concentrations of growth hormone were lower in bipolar disorder patients, suggesting a potential involvement of growth hormone in the development of bipolar disorder.

MOLECULAR PSYCHIATRY (2022)

Article Immunology

Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes

Anniella Isgren, Carl Sellgren, Carl-Johan Ekman, Jessica Holmen-Larsson, Kaj Blennow, Henrik Zetterberg, Joel Jakobsson, Mikael Landen

BRAIN BEHAVIOR AND IMMUNITY (2017)

Article Medicine, General & Internal

Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder

Noriko Yoshimi, Takashi Futamura, Keiji Kakumoto, Alireza M. Salehi, Carl M. Sellgren, Jessica Holmen-Larsson, Joel Jakobssong, Erik Palssong, Mikael Landen, Kenji Hashimoto

BBA CLINICAL (2016)

暂无数据